Who is sponsoring NCT04271722?

NCT04271722 is sponsored by Centro Hospitalar Lisboa Norte.

What drugs are being tested in NCT04271722?

Interventions in NCT04271722: Cervical ripening.

What condition does NCT04271722 study?

NCT04271722 studies Labor; Forced or Induced, Affecting Fetus or Newborn, Labor Onset and Length Abnormalities.

Is NCT04271722 still recruiting?

NCT04271722 is currently completed. Last updated 31 May 2024.

Last reviewed 2024-05-31 · How we verify

NCT04271722

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Evaluation of Cervical Ripening in the Outpatient Setting

Completed NA Last updated 31 May 2024

What this trial tests

NA trial testing Cervical ripening in Labor; Forced or Induced, Affecting Fetus or Newborn in 101 participants. Completed in 30 December 2022.

Timeline

15 January 2020

Primary endpoint
30 December 2022

30 December 2022

Quick facts

Lead sponsor	Centro Hospitalar Lisboa Norte
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	101
Start date	15 January 2020
Primary completion	30 December 2022
Estimated completion	30 December 2022
Sites	1 location across Portugal

Drugs / interventions tested

Cervical ripening

Conditions studied

Labor; Forced or Induced, Affecting Fetus or Newborn — all drugs for Labor; Forced or Induced, Affecting Fetus or Newborn →
Labor Onset and Length Abnormalities — all drugs for Labor Onset and Length Abnormalities →

Sponsor

Centro Hospitalar Lisboa Norte

Who can join

Adults 18 to 45, female only, with Labor; Forced or Induced, Affecting Fetus or Newborn or Labor Onset and Length Abnormalities. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A randomized controlled trial of mifepristone 200mg vs balloon catheter for cervical ripening.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Outpatient cervical ripening with Foley balloon or mifepristone: Insights into the time taken to reach the active phase of labor.
Carvalho-Afonso M, Antunes M, Fonseca A, Ayres-de-Campos D. · · 2026 · cited 1× · PMID 40801537 · DOI 10.1002/ijgo.70468

Verify or expand the search:

Other Centro Hospitalar Lisboa Norte trials

Trials by the same sponsor.

NCT05763498 — Uterine Junctional Zone and Its Relation to Adverse Obstetrical Outcomes in Assisted Reproductive Technology · recruiting
NCT04878224 — Junctional Zone and Its Relation to Outcomes in Assisted Reproductive Technology · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04271722 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centro Hospitalar Lisboa Norte
Last refreshed: 31 May 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04271722.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing